Results
9
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
9 companies
Revenio Group Oyj
Market Cap: €609.2m
Provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally.
REG1V
€22.90
7D
-3.2%
1Y
-35.2%
Nightingale Health Oyj
Market Cap: €147.7m
A health technology company, offers health data platform that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally.
HEALTH
€2.45
7D
-5.8%
1Y
-18.3%
Biohit Oyj
Market Cap: €43.3m
A biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide.
BIOBV
€2.85
7D
3.3%
1Y
31.9%
Optomed Oyj
Market Cap: €74.2m
Manufactures and sells handheld fundus cameras in Finland, rest of Europe, and internationally.
OPTOMED
€3.77
7D
0.9%
1Y
-16.9%
Oriola Oyj
Market Cap: €218.6m
Engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally.
ORIOLA
€1.18
7D
-2.3%
1Y
28.7%
Modulight Oyj
Market Cap: €52.5m
Designs, manufactures, and markets lasers products for medical and other diagnostic applications.
MODU
€1.24
7D
-10.4%
1Y
10.4%
Aiforia Technologies Oyj
Market Cap: €87.2m
Together with its subsidiary, Aiforia Inc., provides AI-based image analysis software used in clinical, preclinical, and academic laboratories to pathologists and researchers in Finland, rest of Europe, North America, and internationally.
AIFORIA
€2.76
7D
-3.5%
1Y
-29.2%
Pihlajalinna Oyj
Market Cap: €361.9m
Provides social, healthcare, and wellbeing services to private persons, companies, insurance companies, and public sector entities in Finland.
PIHLIS
€16.10
7D
-3.9%
1Y
66.0%
Nexstim
Market Cap: €94.8m
A medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally.
NXTMH
€13.20
7D
3.5%
1Y
225.1%